Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Production of ginsenoside F1 using commercial enzyme Cellulase KN

  • Wang, Yu (College of Biotechnology, Dalian Polytechnic University) ;
  • Choi, Kang-Duk (Genomic Informatics Center, Graduate School of Future Convergence Technology, Hankyong National University) ;
  • Yu, Hongshan (College of Biotechnology, Dalian Polytechnic University) ;
  • Jin, Fengxie (College of Biotechnology, Dalian Polytechnic University) ;
  • Im, Wan-Taek (Department of Biotechnology, Hankyong National University)
  • Received : 2014.07.27
  • Accepted : 2015.06.15
  • Published : 2016.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Ginsenoside F1, a pharmaceutical component of ginseng, is known to have antiaging, antioxidant, anticancer, and keratinocyte protective effects. However, the usage of ginsenoside F1 is restricted owing to the small amount found in Korean ginseng. Methods: To enhance the production of ginsenoside F1 as a 10 g unit with high specificity, yield, and purity, an enzymatic bioconversion method was developed to adopt the commercial enzyme Cellulase KN from Aspergillus niger with food grade, which has ginsenoside-transforming ability. The proposed optimum reaction conditions of Cellulase KN were pH 5.0 and $50^{\circ}C$. Results: Cellulase KN could effectively transform the ginsenosides Re and Rg1 into F1. A scaled-up biotransformation reaction was performed in a 10 L jar fermenter at pH 5.0 and $50^{\circ}C$ for 48 h with protopanaxatriol-type ginsenoside mixture (at a concentration of 10 mg/mL) from ginseng roots. Finally, 13.0 g of F1 was produced from 50 g of protopanaxatriol-type ginsenoside mixture with $91.5{\pm}1.1%$ chromatographic purity. Conclusion: The results suggest that this enzymatic method could be exploited usefully for the preparation of ginsenoside F1 to be used in cosmetic, functional food, and pharmaceutical industries.

Keywords

References

  1. Bae M, Jang S, Lim JW, Kang J, Bak EJ, Cha JH, Kim H. Protective effect of Korean Red Ginseng extract against Helicobacter pylori-induced gastric inflammation in Mongolian gerbils. J Ginseng Res 2014;38:8-15. https://doi.org/10.1016/j.jgr.2013.11.005
  2. Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 2014;38:161-6. https://doi.org/10.1016/j.jgr.2014.03.001
  3. Park HJ, Kim DH, Park SJ, Kim JM, Ryu JH. Ginseng in traditional herbal prescriptions. J Ginseng Res 2012;36:225-41. https://doi.org/10.5142/jgr.2012.36.3.225
  4. Chae S, Kang KA, Chang WY, Kim MJ, Lee SJ, Lee YS, Kim HS, Kim DH, Hyun JW. Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo. J Agric Food Chem 2009;57:5777-82. https://doi.org/10.1021/jf900331g
  5. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, Samukawa K, Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995;18:1197-202. https://doi.org/10.1248/bpb.18.1197
  6. Song X, Zang L, Hu S. Amplified immune response by ginsenoside-based nanoparticles (ginsomes). Vaccine 2009;27:2306-11. https://doi.org/10.1016/j.vaccine.2009.02.040
  7. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside Rc by human intestinal bacteria and its related anti-allergic activity. Biol Pharm Bull 2002;25:743-7. https://doi.org/10.1248/bpb.25.743
  8. Liu ZQ, Luo XY, Liu GZ, Chen YP, Wang ZC, Sun YX. In vitro study of the relationship between the structure of ginsenoside and its anti-oxidative or pro-oxidative activity in free radical induced hemolysis of human erythrocytes. J Agric Food Chem 2003;51:2555-8. https://doi.org/10.1021/jf026228i
  9. Lee HU, Bae EA, Han MJ, Kim NJ, Kim DH. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int 2005;25:1069-73. https://doi.org/10.1111/j.1478-3231.2005.01068.x
  10. Stavro PM, Woo M, Heim TF, Leiter LA, Vuksan V. North American ginseng exerts a neutral effect on blood pressure in individuals with hypertension. Hypertension 2005;46:406-11. https://doi.org/10.1161/01.HYP.0000173424.77483.1e
  11. Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2009;55:1-99.
  12. Bae EA, Shin JE, Kim DH. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull 2005;28:1903-8. https://doi.org/10.1248/bpb.28.1903
  13. Lee EH, Cho SY, Kim SJ, Shin ES, Chang HK, Shin ES, Chang HK, Kim DK, Yeom MH, Woe SK, et al. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. J Invest Dermatol 2003;121:607-13. https://doi.org/10.1046/j.1523-1747.2003.12425.x
  14. Yoo DS, Rho HS, Lee YG, Yeom MH, Kim DH, Lee SJ, Hong S, Lee J, Cho JY. Ginsenoside F1 modulates cellular responses of skin melanoma cells. J Ginseng Res 2011;35:86-91. https://doi.org/10.5142/jgr.2011.35.1.086
  15. Liu Y, Ma H, Zhang JW, Deng MC, Yang L. Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes. Planta Med 2006;72:126-31. https://doi.org/10.1055/s-2005-873197
  16. Kim YS, Yoo MH, Lee GW, Choi JG, Kim KR, Oh DK. Ginsenoside F1 production from ginsenoside Rg1 by a purified ${\beta}$-glucosidase from Fusarium moniliforme var. subglutinans. Biotechnol Lett 2011;33:2457-61. https://doi.org/10.1007/s10529-011-0719-0
  17. Ko SR, Choi KJ, Suzuki K, Suzuki Y. Enzymatic preparation of ginsenosides Rg2, Rh1, and F1. Chem Pharm Bull 2003;51:404-8. https://doi.org/10.1248/cpb.51.404
  18. Quan LH, Min JW, Sathiyamoorthy S, Yang DU, Kim YJ, Yang DC. Biotransformation of ginsenosides Re and Rg1 into ginsenosides Rg2 and Rh1 by recombinant ${\beta}$-glucosidase. Biotechnol Lett 2012;34:913-7. https://doi.org/10.1007/s10529-012-0849-z
  19. Cui CH, Kim SC, Im WT. Characterization of the ginsenoside-transforming recombinant ${\beta}$-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides. Appl Microbiol Biotech 2013;97:649-59. https://doi.org/10.1007/s00253-012-4324-5
  20. Cui CH, Liu QM, Kim JK, Sung BH, Kim SG, Kim SC, Im WT. Identification and characterization of Mucilaginibacter sp. QM49 ${\beta}$-glucosidase and its use in producing the pharmaceutically active minor ginsenosides, Rh1(S) and Rg2(S). Appl Environ Microbiol 2013;79:5788-98. https://doi.org/10.1128/AEM.01150-13
  21. Kim JK, Cui CH, Yoon MH, Kim SC, Im WT. Bioconversion of major ginsenosides Rg1 to minor ginsenoside F1 using novel recombinant ginsenoside hydrolyzing glycosidase cloned from Sanguibacter keddieii and enzyme characterization. J Biotechnol 2012;161:294-301. https://doi.org/10.1016/j.jbiotec.2012.06.021
  22. Ruan CC, Zhang H, Zhang LX, Liu Z, Sun GZ, Lei J, Qin YX, Zheng YN, Li X, Pan HY. Biotransformation of ginsenoside Rf to Rh1 by recombinant bglucosidase. Molecules 2009;14:2043-8. https://doi.org/10.3390/molecules14062043
  23. Jonathan K, Paivi L, Tuula T. Cellulase families and their genes. Trends Biotechnol 1987;9:255-61.

Cited by

  1. Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products vol.26, pp.5, 2016, https://doi.org/10.1007/s10068-017-0159-2
  2. Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling vol.8, pp.None, 2017, https://doi.org/10.3389/fphar.2017.00953
  3. Production of the Rare Ginsenoside Rh2-MIX (20(S)-Rh2, 20(R)-Rh2, Rk2, and Rh3) by Enzymatic Conversion Combined with Acid Treatment and Evaluation of Its Anti-Cancer Activity vol.27, pp.7, 2016, https://doi.org/10.4014/jmb.1701.01077
  4. Gram-Scale Production of Ginsenoside F1 Using a Recombinant Bacterial β-Glucosidase vol.27, pp.9, 2016, https://doi.org/10.4014/jmb.1703.03006
  5. Comprehensive Profiling and Quantification of Ginsenosides in the Root, Stem, Leaf, and Berry of Panax ginseng by UPLC-QTOF/MS vol.22, pp.12, 2017, https://doi.org/10.3390/molecules22122147
  6. Enhanced Production of Protopanaxatriol from Ginsenoside Re and Rg1 Using a Recombinant Bacterial β-glucosidase vol.24, pp.4, 2016, https://doi.org/10.1007/s12257-019-0090-x
  7. Biocatalytic strategies for the production of ginsenosides using glycosidase: current state and perspectives vol.104, pp.9, 2016, https://doi.org/10.1007/s00253-020-10455-9
  8. Diversity of Ginsenoside Profiles Produced by Various Processing Technologies vol.25, pp.19, 2020, https://doi.org/10.3390/molecules25194390
  9. 상업용 β-glucanase를 이용한 홍삼유래 사포닌으로부터 Ginsnoside Rd 의 생물 전환 vol.46, pp.4, 2016, https://doi.org/10.15230/scsk.2020.46.4.349
  10. Production of minor ginsenosides by combining Stereum hirsutum and cellulase vol.16, pp.8, 2016, https://doi.org/10.1371/journal.pone.0255899